Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome after Allogeneic Stem Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network Protocol

✍ Scribed by Yanik, Gregory A.; Horowitz, Mary M.; Weisdorf, Daniel J.; Logan, Brent R.; Ho, Vincent T.; Soiffer, Robert J.; Carter, Shelly L.; Wu, Juan; Wingard, John R.; Difronzo, Nancy L.; Ferrara, James L.; Giralt, Sergio; Madtes, David K.; Drexler, Rebecca; White, Eric S.; Cooke, Kenneth R.

• Book ID: 121809616
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 347 KB
• Volume: 20
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2014.02.026